Organicell Regenerative Medicine, Inc.
OCEL · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.7% | 5.4% | -3.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 82.5% | 77.7% | 82.5% | 61.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -158.6% | -121.3% | -115% | -73.2% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -158.7% | -121.1% | -114% | 34.8% |
| EPS Diluted | -0.32 | -0.22 | -0.2 | 0.062 |
| % Growth | -45.5% | -10% | -421.5% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |